Shilpa Medicare Jadcherla facility gets GMP certification from Russia
Chemical

Shilpa Medicare Jadcherla facility gets GMP certification from Russia

The GMP certificate is valid for three years until April 2024.

  • By ICN Bureau | May 29, 2021

Shilpa Medicare Ltd's Finished Dosage Formulation Facility (Sterile and Non-sterile) located at S-20 to S-26, Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India has been issued GMP certification by Ministry of Industry and Trade of the Russian Federation for the GMP inspection held from 22-02-2021 to 26-02-2021. There were No Critical, Major and Minor observations found during GMP inspection process.

The GMP certificate is valid for three years until April 2024.

Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport

Upcoming Conferences

Chem Connect 2025

August 21, 2025

Other Related stories

Startups

Petrochemical

Energy

Digitization